P

Inventor

HOLGATE ROBERT GEORGE EDWARD

GB15 patents
⚠️ This page may combine multiple inventors who share the name “HOLGATE ROBERT GEORGE EDWARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

REDWOOD BIOSCIENCE INC

3 patents
US9181343B2Nov 10, 2015

Antibody specific for CD22 and methods of use thereof

REDWOOD BIOSCIENCE INC13 citations92
US10259871B2Apr 16, 2019

Antibody specific for CD22 and methods of use thereof

REDWOOD BIOSCIENCE INC4 citations83
US12116409B2Oct 15, 2024

Antibody specific for CD22 and methods of use thereof

REDWOOD BIOSCIENCE INC0 citations62

JONES TIMOTHY DAVID

2 patents
US9714290B2Jul 25, 2017

Humanised anti CTLA-4 antibodies

JONES TIMOTHY DAVID18 citations82
US9321841B2Apr 26, 2016

Humanised anti-CD52 antibodies

JONES TIMOTHY DAVID11 citations82

IMMUNEXT INC

2 patents
US10874738B2Dec 29, 2020

Anti-CD154 antibody having improved binding, functional and safety characteristics

IMMUNEXT INC3 citations70
US11596689B2Mar 7, 2023

Methods of immunosuppression comprising administering an anti-CD154 antibody

IMMUNEXT INC1 citations59

POLYTHERICS LTD

2 patents
US11059903B2Jul 13, 2021

Anti-PSMA antibodies, uses thereof and conjugates thereof

POLYTHERICS LTD4 citations68
US11485792B2Nov 1, 2022

Antibodies, uses thereof and conjugates thereof

POLYTHERICS LTD1 citations62

PROCLARA BIOSCIENCES INC

1 patent
US9988444B2Jun 5, 2018

Polypeptides comprising a modified bacteriophage g3p amino acid sequence with reduced immunogenicity

PROCLARA BIOSCIENCES INC4 citations72

SYNTIMMUNE INC

1 patent
US10626175B2Apr 21, 2020

Humanized affinity matured anti-FcRn antibodies

SYNTIMMUNE INC2 citations65

C2N DIAGNOSTICS LLC

1 patent
US9957317B2May 1, 2018

Humanized anti-tau antibodies

C2N DIAGNOSTICS LLC2 citations65

CELLDEX THERAPEUTICS INC

1 patent
US11884734B2Jan 30, 2024

Anti-MET antibodies and methods of use thereof

CELLDEX THERAPEUTICS INC0 citations55

BRIGHAM & WOMENS HOSPITAL INC

1 patent
US12173066B2Dec 24, 2024

Humanized and affinity-matured anti-CEACAM1 antibodies

BRIGHAM & WOMENS HOSPITAL INC0 citations54

MINTER RALPH RAYMOND

1 patent
US8518645B2Aug 27, 2013

Method of mutagenesis

MINTER RALPH RAYMOND1 citations39